Healthy cells of the patient would.

The project is focused on the improvement reconstructive surgery performed on the breast after a lumpectomy. Healthy cells of the patient would, with a degradable biomaterial of Engineering properties are combined. The tissue biomaterial would be injected following the lumpectomy, in the patient. Earlier studies have shown that the development of tissue fills the tissue defect gradually absorbed as the material into the body.

Burg said the concept of an injectable biomaterial for breast tissue reconstruction in animal models in animal models and the anti-cancer biomaterial developed in a lab – engineered tissue system at the institute.This decision will this to this life-saving technology, said CMS Acting an administrator Leslie V. Norwalk, and certified by the Joint Commission, we will ensure and patient cultivation into experience institutions. .